Medical News

RSS

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

According to SDI's Pharmaceutical Company Image 2010 study, Novo Nordisk was ranked by endocrinologists as the top company overall. The company was mentioned by 62% of the endocrinologists who participated in the annual study - a substantial increase from last year, when it was mentioned by 52% of participants and ranked second.

7 Jul 2010

Investment report on Hemispherx BioPharma

MicroStockProfit.com announces an investment report featuring Hemispherx BioPharma Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

7 Jul 2010

Changes in Medicare Part B therapy rates likely to reduce Kindred Healthcare's revenues by $11M per year

Kindred Healthcare, Inc. today provided its estimate of the revenue effect of proposed rate changes to Medicare Part B therapy services included in the proposed Medicare Physician Fee Schedule rule. The proposed rule was released by the Centers for Medicare and Medicaid Services ("CMS") on June 25. The proposed rule is subject to a 60-day public comment period and is scheduled to become effective January 1, 2011.

7 Jul 2010

Modern Plastics adds MediPEEK-IM products

Modern Plastics has added extruded-plate MediPEEK-IM, a permanent implantable medical-grade PEEK (Polyetheretherketone), to its medical-grade plastics offering. MediPEEK-IM is a high-performance semi-crystalline thermoplastic designed for long-term body contact. The resin is produced to ASTM F2026 specifications and has been extensively tested to ISO-10993 requirements.

7 Jul 2010

ODA suggests tips for good oral hygiene to parents and kids

The Ontario Dental Association is asking parents to put oral health at the top of their kids camp preparation list. An oral care kit should be on the packing list, complete with a toothbrush, fluoride toothpaste and dental floss.

7 Jul 2010

Bilinguals more effective in certain executive functions: Study

The research group of Neuropsychology and Functional Neuroimaging at the Universitat Jaume I of Castellón, led by Professor of Basic Psychology, César ávila Rivera, has reported that bilinguals are faster and more efficient in certain tasks in which executive functions are used due to a different form of cerebral control.

7 Jul 2010

Cipher Pharmaceuticals reaches cumulative sales milestone for Lipofen

Cipher Pharmaceuticals Inc. today announced that it reached a cumulative sales milestone for Lipofen, the Company's fenofibrate product. Achieving this target triggers a US$1.0 million milestone payment from Kowa Pharmaceuticals America Inc., Cipher's U.S. marketing and distribution partner, which will be reflected in Cipher's revenue for the second quarter of fiscal 2010.

7 Jul 2010

Use of NSAIDs do not increase risk of heart attack in elderly patients: Study

Commonly used painkillers like ibuprofen do not increase the risk of heart attack in the elderly population, according to a new study. Researchers found that the use of these drugs - also called non-steroidal anti-inflammatory drugs - was also associated with a lower risk of death although they are not sure why.

7 Jul 2010

Northwest Biotherapeutics raises $2.65M during second-quarter

Northwest Biotherapeutics, Inc., developer of the DCVax® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors. The funding included $1.75 million in purchases of restricted common stock of the Company by a number of private investors, together with purchases of restricted Common Stock totaling $900,000 by SDS Capital and by Ms. Linda F. Powers, Chair of the Company's Board.

7 Jul 2010

Rutgers researchers report genetic coding responsible for making QPM kernels sturdy

Rutgers researchers have discovered the basis for what makes corn kernels hard, a quality that allows corn to be easily harvested, stored and transported. The findings could lead to better hybrids and increase the supply for people in developing countries who rely on it as a nutritional staple.

7 Jul 2010

NIH awards $2.8M grant for development of diagnostic multiplex testing platform with BMB technology

Applied BioCode, Inc. and Maxwell Sensors Inc. announced today that they have received a $2.8M three-year grant from the Recovery Act Limited Competition: National Institutes of Health (NIH), for the development of a high throughput diagnostic multiplex testing platform using their Barcoded Magnetic Beads (BMB) technology for various high value immunodiagnostics and molecular diagnostic tests.

7 Jul 2010

Scientists identify potential disease genes in humans and mice

An international consortium of scientists of Helmholtz Zentrum München and the University of Toronto has identified previously unknown potential disease genes in humans and mice. Genes on the X chromosome, which regulate embryonic development, are the focus of the current publication in the renowned journal Genome Research. Men have only one X chromosome, and therefore mutations on this chromosome disproportionately affect males, frequently leading to serious diseases such as hemophilia, muscular dystrophy and mental retardation.

7 Jul 2010

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.

7 Jul 2010

Alnylam Pharmaceuticals initiates dosing in Phase I human clinical study with ALN-TTR01

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today it has initiated dosing in a Phase I human clinical study with ALN-TTR01. The study is aimed at evaluating the safety and tolerability of ALN-TTR01 in patients with transthyretin -mediated amyloidosis, and is also designed to provide preliminary data on human proof of concept based on measurements of TTR serum levels.

7 Jul 2010

DATATRAK announces private placement of 357,857 common shares to directors, management

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced that it privately placed 357,857 common shares at a price of approximately $0.53 per share with certain members of its Board of Directors and management team.

7 Jul 2010

USW requests oil industry to re-open pattern agreement and negotiate health, safety provisions

United Steelworkers Vice President Gary Beevers, who heads the union's oil sector, sent a request to the oil industry to re-open the National Oil Bargaining pattern agreement and negotiate health and safety provisions.

7 Jul 2010

Nile completes dosing in CD-NP Phase II study for acute decompensated heart failure

Nile Therapeutics, Inc., a biopharmaceutical company focused on the development of novel therapeutics for cardiovascular disease, today announced that it has completed the dosing of the last patient in NIL-CDNP-CT005, an open-label, single-blind, placebo-controlled Phase II study of CD-NP in patients with acute decompensated heart failure, or ADHF. The study was designed to provide additional information on the safety and tolerability of CD-NP when infused for up to 72 hours in patients with ADHF and mild to moderate renal insufficiency.

7 Jul 2010

First Edition: July 7, 2010

Today's biggest health policy news surrounds an announcement by the White House that President Obama will install a new Medicare and Medicaid chief with a recess appointment the bypasses the confirmation process.

7 Jul 2010

McCarthy Capital leads $50M investment in Life Care Companies

McCarthy Capital Corporation recently led a $50 million investment in a privately-held company, Life Care Companies LLC. Headquartered in Des Moines, Iowa, the company does business as Life Care Services (LCS) and is a national leader in providing services to senior living communities.

7 Jul 2010

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Invision Sally Jobe is among the first diagnostic imaging networks in the nation to offer a new breast ultrasound technology for the early detection of cancer. Screening Breast Ultrasound is a highly effective technology developed to complement mammography in women with radiologically dense breasts and other risk factors.

7 Jul 2010

Medical News

SDI Pharmaceutical Company Image 2010 study: Novo Nordisk ranked top among endocrinologists

Investment report on Hemispherx BioPharma

Changes in Medicare Part B therapy rates likely to reduce Kindred Healthcare's revenues by $11M per year

Modern Plastics adds MediPEEK-IM products

ODA suggests tips for good oral hygiene to parents and kids

Bilinguals more effective in certain executive functions: Study

Cipher Pharmaceuticals reaches cumulative sales milestone for Lipofen

Use of NSAIDs do not increase risk of heart attack in elderly patients: Study

Northwest Biotherapeutics raises $2.65M during second-quarter

Rutgers researchers report genetic coding responsible for making QPM kernels sturdy

NIH awards $2.8M grant for development of diagnostic multiplex testing platform with BMB technology

Scientists identify potential disease genes in humans and mice

PolyMedix receives NIH grant to develop defensin-mimetic antimicrobial compounds for malaria

Alnylam Pharmaceuticals initiates dosing in Phase I human clinical study with ALN-TTR01

DATATRAK announces private placement of 357,857 common shares to directors, management

USW requests oil industry to re-open pattern agreement and negotiate health, safety provisions

Nile completes dosing in CD-NP Phase II study for acute decompensated heart failure

First Edition: July 7, 2010

McCarthy Capital leads $50M investment in Life Care Companies

Invision Sally Jobe introduces SBU technology for early detection of breast cancer

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News